Catalyst4, Inc.
SEC Form 4 insider trading activity
Catalyst4, Inc. has filed 3 SEC Form 4 filings (7 transaction rows) across 1 company, with disclosures dating back to 2025. 3 of those filings fall inside the rolling window. Most recent filing: Aug 18, 2026.
On the most recent filing, Catalyst4, Inc. is listed as 10% Owner at MapLight Therapeutics, Inc. Inside the rolling window, Catalyst4, Inc. reported 5 open-market purchases totaling $157.9M in MLPT and no open-market sales. The largest disclosed transaction in the window is a purchase of 5,441,176 MLPT shares on Oct 28, 2025, worth $92.5M.
Companies traded
Insider Buying
$157.9M
reported purchases (SEC code P)
Insider Selling
$0
reported sales (SEC code S)
Companies
1
in the rolling window
Frequently asked questions
How many SEC Form 4 filings has Catalyst4, Inc. made?
Catalyst4, Inc. has filed 3 SEC Form 4 filings (7 transaction rows) across 1 company since 2025.
Which companies does Catalyst4, Inc. trade?
Catalyst4, Inc. has filed SEC Form 4 disclosures for 1 company, including MLPT.
When was Catalyst4, Inc.'s most recent SEC Form 4 filing?
Catalyst4, Inc.'s most recent SEC Form 4 filing on Tracefour is dated Aug 18, 2026.
What is Catalyst4, Inc.'s total buy and sell value in the current window?
Inside the rolling retention window, Catalyst4, Inc. bought $157.9M and sold $0 based on SEC Form 4 filings.
What was Catalyst4, Inc.'s largest disclosed transaction?
The largest disclosed transaction in the current window is a purchase of 5,441,176 MLPT shares on 2025-10-28, worth $92.5M, per SEC Form 4 filings.